School of Dentistry and Jonsson Comprehensive Cancer Center, University of California , Los Angeles, California 90095, United States.
Center for Advanced Proteomics Research, Rutgers University, New Jersey Medical School , Newark, New Jersey 07103, United States.
J Proteome Res. 2017 Nov 3;16(11):3961-3968. doi: 10.1021/acs.jproteome.7b00247. Epub 2017 Oct 2.
Deregulated expression of SOX11 has been shown to be involved in the progression of various types of cancer. However, the role of SOX11 in head and neck cancer remains largely unknown. In this study, coimmunoprecipitation (Co-IP) and liquid chromatography-tandem mass spectrometry (LC-MS/MS) were performed to identify the proteins that bind to SOX11 at significantly higher levels in head and neck cancer cells than in normal human oral keratinocytes. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses indicated that many potential SOX11-binding partners were associated with protein synthesis, cell metabolism, and cell-cell adhesion. One of the identified proteins, heat shock protein 90 alpha (HSP90α), was selected for further investigation. The binding of HSP90α with SOX11 in head and neck cancer cells was validated by Co-IP with western blotting. In addition, HSP90α was found to be remarkably overexpressed in head and neck cancer cell lines when compared to its level in normal human oral keratinocytes, and knockdown of HSP90α inhibited the proliferation and invasion capacity of these cancer cells. On the basis of The Cancer Genome Atlas (TCGA) data analysis, HSP90AA1 gene was overexpressed in head and neck cancer tissues compared to normal controls and increased HSP90AA1 gene expression was positively associated with extracapsular spread and clinical stage. Head and neck cancer patients with higher HSP90AA1 expression had significantly poorer long-term overall and disease-free survival rates than those with lower HSP90AA1 expression. Collectively, our studies indicate that SOX11 binds to HSP90α, a highly overexpressed protein that may promote invasion and progression of head and neck cancer cells.
SOX11 的失调表达已被证明参与了多种类型癌症的进展。然而,SOX11 在头颈部癌症中的作用在很大程度上仍然未知。在这项研究中,通过共免疫沉淀(Co-IP)和液相色谱-串联质谱(LC-MS/MS)鉴定了在头颈部癌细胞中与 SOX11 结合水平显著高于正常人口腔角质形成细胞的蛋白质。基因本体论和京都基因与基因组百科全书(KEGG)通路分析表明,许多潜在的 SOX11 结合伴侣与蛋白质合成、细胞代谢和细胞-细胞黏附有关。鉴定出的一种蛋白质,热休克蛋白 90α(HSP90α),被选为进一步研究的对象。通过 Co-IP 和 Western blot 验证了 HSP90α与头颈部癌细胞中 SOX11 的结合。此外,与正常人口腔角质形成细胞相比,HSP90α在头颈部癌细胞系中显著过表达,并且敲低 HSP90α 抑制了这些癌细胞的增殖和侵袭能力。基于癌症基因组图谱(TCGA)数据分析,与正常对照相比,HSP90AA1 基因在头颈部癌组织中过表达,并且 HSP90AA1 基因表达的增加与细胞外扩散和临床分期呈正相关。HSP90AA1 表达较高的头颈部癌症患者的长期总生存率和无病生存率明显低于 HSP90AA1 表达较低的患者。总之,我们的研究表明,SOX11 与 HSP90α结合,HSP90α 是一种高度过表达的蛋白,可能促进头颈部癌细胞的侵袭和进展。